Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001015820-14-000008
Filing Date
2014-03-03
Accepted
2014-03-03 17:16:42
Documents
12
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 20-F a201320-f.htm 20-F 2912705
2 EXHIBIT a201320-flistofsubsidiarie.htm EX-8.1 21844
3 EXHIBIT a201320-fexhibit121.htm EX-12.1 11881
4 EXHIBIT a201320-fexhibit122.htm EX-12.2 11878
5 EXHIBIT a201320-fexhibit131.htm EX-13.1 15030
6 EXHIBIT a201320-fconsentexhibit151.htm EX-15.1 12744
  Complete submission text file 0001015820-14-000008.txt   18784616

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT qgen-20131231.xml EX-101.INS 3104583
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT qgen-20131231.xsd EX-101.SCH 105497
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT qgen-20131231_cal.xml EX-101.CAL 167976
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT qgen-20131231_def.xml EX-101.DEF 423684
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT qgen-20131231_lab.xml EX-101.LAB 1324929
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT qgen-20131231_pre.xml EX-101.PRE 747714
Mailing Address SPOORSTRAAT 50 KJ VENLO P7 5911
Business Address SPOORSTRAAT 50 KJ VENLO P7 5911 31-77-320-8400
QIAGEN NV (Filer) CIK: 0001015820 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 000-28564 | Film No.: 14661465
SIC: 2836 Biological Products, (No Diagnostic Substances)